New Market Study Published: Ear Care in Switzerland
Ear care once again registered a decline in 2012, falling by 3% in current value terms. This development fully corresponded with the performance during the review period, which saw a negative CAGR of 3% in current value terms. The poor performance of ear care in 2012 and during the review period can be attributed to the low demand for such OTC products. Swiss consumers with ear ache or other ear problems would rather seek a doctor's advice than try self-medication....
View full press release